The Food and Drug Administration has recalled more than 110,000 bottles of blood pressure medication after it was found that a key ingredient in the drugs was compromised.
The medication is called Ramipril and is classified as an angiotensin-converting enzyme inhibitor, which is used to treat high blood pressure and other health issues, according to the Mayo Clinic.
The drug helps treat high blood pressure by relaxing blood vessels, which then increases the supply of blood and oxygen to the heart. The medication can also be used by those with heart failure after a heart attack.
The FDA shared that the recall for 112,770 bottles of Ramipril, which is produced by Lupin Pharmaceuticals Inc., was first issued on Oct. 23, but on Nov. 19, the FDA issued a risk clarification update.
In the update, the FDA said that an “active pharmaceutical ingredient was sourced from an unapproved vendor.”
The FDA noted that there may be no health consequences that are medically serious but that it is still advising people who take the medication to avoid certain Ramipril 2.5 mg capsules. The affected bottles came in 90, 100, and 500 counts.
For the full list of affected bottles, visit the recall notice here.
No injuries or side effects have been reported by the FDA as a result of taking the drug at this time.